GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...
Atrial fibrillation was diagnosed in 477 of 1,501 (31.8%) participants in the monitoring group and 550 of 4,503 (12.2%) participants in the control group (HR 3.17, 95% CI 2.81-3.59, P<0.001), reported ...
Please provide your email address to receive an email when new articles are posted on . Continuous implantable loop recorder monitoring resulted in a threefold increase in atrial fibrillation ...
Using an implantable loop recorder (ILR) to screen older individuals for atrial fibrillation (AF) may be more beneficial when NT-proBNP levels are high, according to a post hoc analysis of the LOOP ...
Three general types of instruments for acquiring data are currently available: continuous recorders, intermittent or event recorders, and instruments for real-time recording and transmission of ECGs ( ...
The longer and continuous recording duration of an event loop recorder may offer physicians the advantage of recording paroxysmal and often silent episodes of atrial fibrillation that would not be ...
Doctors at Columbus Community Hospital now have a high-tech new tool that can help them diagnose irregular heart rhythms that may not show up during standard testing. The tool, called a cardiac loop ...
While the traditional Holter concept has been slow to advance, other rhythm recording options are available. The alternatives and various features are summarized in Table 1. This includes the event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results